DEUTSCHE BANK AG\ - IMMUNE PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of IMMUNE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$0280.0%0.00%
Q4 2016$0280.0%0.00%
Q3 2016$0280.0%0.00%
Q2 2016$0
-100.0%
28
-99.9%
0.00%
Q4 2014$42,000
-44.0%
22,4660.0%0.00%
Q3 2014$75,00022,4660.00%
Other shareholders
IMMUNE PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Geduld E E 35,000$63,0000.04%
Ifrah Financial Services, Inc. 21,956$39,0000.02%
Bank Pictet & Cie (Europe) AG 12,900$23,0000.01%
Pine River Capital Management L.P. 250,000$260,0000.00%
Virtu KCG Holdings LLC 55,599$100,0000.00%
A.R.T. Advisors, LLC 10,408$18,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 1,000$2,0000.00%
CITIGROUP INC 255$00.00%
GOLDMAN SACHS GROUP INC 33,616$60,0000.00%
MORGAN STANLEY 40$00.00%
View complete list of IMMUNE PHARMACEUTICALS INC shareholders